Cite
HARVARD Citation
Shapiro, S. et al. (2017). Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1). Respiratory medicine. pp. 84-92. [Online].